US Patent Issued to Bristol-Myers Squibb on Oct. 14 for "Compounds and their use for treatment of hemoglobinopathies" (American, Swiss Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,711, issued on Oct. 14, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Compounds and their use for treatment of hemoglobinopathies" was invented by Thomas J. Cummins (San Diego), Scott Arne Johnson (San Diego), Hannah L. Powers (San Diego) and Giorgio Tamo (Biel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds and methods for the prevention and/or treatment of hemoglobinopathies. Also provided herein are such compounds for use in such methods. Also disclosed herein are pharmaceutical compositions comprising such compounds for use in such methods of preventing or treating hemoglobinopathies."

T...